A carregar...
Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status
The vascular endothelial growth factor (VEGF) signaling pathway appears to be the dominant pathway involved in tumor angiogenesis, providing a rationale for targeting the VEGF receptors (VEGFR-1, -2, and -3) in the treatment of cancers. In particular, VEGF signaling is thought to be important in ren...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Current Science Inc.
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047052/ https://ncbi.nlm.nih.gov/pubmed/21318618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-011-0154-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|